Literature DB >> 17766215

Epidemiologic study on work-related eye injuries in Kaohsiung, Taiwan.

Chi-Kung Ho1, Ya-Lin Yen, Cheng-Hsien Chang, Hung-Che Chiang, Ying-Ying Shen, Po-Ya Chang.   

Abstract

To describe the epidemiologic features of work-related eye injuries in Kaohsiung, a hospital-based study was performed. Four hundred and eighty-six patients who were treated at emergency service or were admitted to the ophthalmology ward over a 4-year period were reviewed. Among these, 38.9% of eye injuries in the study were work-related. Male workers had a 3.99 higher odds ratio (OR) than females to suffer from eye injuries (95% confidence interval [CI], 1.99-8.04). Most of the work-related eye injuries occurred in subjects who were 30-49 years old (OR, 3.02, and 95% CI, 1.56-5.82, when compared with those aged < or = 29 years). The most common type of eye injury in the occupational exposure group was foreign body injury (31.2%), followed by blunt injuries (20.6%), chemical burn (19.6%), UV light radiation (12.7%), and corneal abrasions (11.6%). On the other hand, in the non-occupational exposure group, the most common types of eye injury were blunt injuries (43.4%), corneal abrasions (28.3%), and foreign body injury (20.2%). Our study found that foreign body injury and blunt injuries were the two highest priority injuries for which prevention strategies should be developed in Kaohsiung city. Furthermore, after advanced examination of types of media that caused eye injuries, we found that being hit by wooden objects around the eye, by flying objects in the eye, and by welding flashes are important risk factors for workers to avoid. In conclusion, most of the occupational eye injuries occurred among male workers aged 30-49 years. Due to the lack of an occupational eye injury surveillance system to monitor the incidence of eye injuries and to undertake risk assessment, preventable occupational eye injuries have not been properly controlled. We hope to provide information for further development of preventive strategies.

Entities:  

Mesh:

Year:  2007        PMID: 17766215     DOI: 10.1016/S1607-551X(08)70054-8

Source DB:  PubMed          Journal:  Kaohsiung J Med Sci        ISSN: 1607-551X            Impact factor:   2.744


  6 in total

1.  [Chemical and thermal eye burns. Conservatíve and surgical options of a stage-dependent therapy].

Authors:  H G Struck; N F Schrage
Journal:  Ophthalmologe       Date:  2011-10       Impact factor: 1.059

2.  The Study of Incidence and Characteristics of Patients with Eye-Related Chief Complaints at the Emergency Department of Thammasat University Hospital.

Authors:  Intanon Imsuwan; Kumpol Amnuaypattanapon; Sakchai Vongkittirux; Yutthaphong Imsuwan
Journal:  Emerg Med Int       Date:  2020-10-19       Impact factor: 1.112

3.  Epidemiological Characteristics of Work-Related Ocular Trauma in Southwest Region of China.

Authors:  Mingming Cai; Jie Zhang
Journal:  Int J Environ Res Public Health       Date:  2015-08-19       Impact factor: 3.390

4.  Description of the epidemiological characteristics of work-related eye injuries in Spain: a retrospective study.

Authors:  Sergio Martin-Prieto; Cristina Álvarez-Peregrina; Israel Thuissard-Vasallo; Carlos Catalina-Romero; Eva Calvo-Bonacho; César Villa-Collar; Miguel Ángel Sánchez-Tena
Journal:  BMJ Open       Date:  2020-10-15       Impact factor: 2.692

5.  Description of Main Predictors for Taking Sick Leave Associated with Work-Related Eye Injuries in Spain.

Authors:  Sergio Martín-Prieto; Cristina Alvarez-Peregrina; Israel Thuissard-Vassallo; Carlos Catalina-Romero; Eva Calvo-Bonacho; César Villa-Collar; Miguel Ángel Sánchez-Tena
Journal:  Int J Environ Res Public Health       Date:  2021-05-13       Impact factor: 3.390

6.  Characteristics of eye injuries, medical cost and return-to-work status among industrial workers: a retrospective study.

Authors:  Rokiah Omar; Nur Syamilah Anan; Izmel Azim Azri; Chiranjib Majumder; Victor Feizal Knight
Journal:  BMJ Open       Date:  2022-01-31       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.